Tenax Therapeutics director Declan Doogan buys 53,000 shares worth $101,760
Tenax Therapeutics director Declan Doogan bought 53,000 common shares at USD 1.92, lifting direct holdings to 55,274 shares. Doogan also reported stock options covering 210,008 shares, with exercise prices ranging from USD 5.75 to USD 3,200. Disclaimer: This news brief was created by Public Technologies (PUBT) using ge